Latest News and Press Releases

Amplify ETFs announces four nominations in three categories in the With Intelligence Mutual Fund and ETF Awards.

BRADENTON, Fla., Jan. 12, 2026 (GLOBE NEWSWIRE) -- First Watch Restaurant Group, Inc. (NASDAQ: FWRG) (“First Watch” or the “Company”), the leading Daytime Dining concept serving breakfast, brunch...

Radiopharm Ventures, LLC, is a joint venture created in 2022 between MD Anderson Cancer Center and Radiopharm TheranosticsLeading candidate Betabart, a monoclonal antibody targeting B7H3, has received...

Octopus AIM VCT 2 plc Publication of Prospectus Octopus AIM VCT 2 plc and Octopus AIM VCT plc (the “Companies”) have today issued a prospectus relating to a proposed offer for subscription for...

Octopus AIM VCT plc Publication of Prospectus Octopus AIM VCT plc and Octopus AIM VCT 2 plc (the “Companies”) have today issued a prospectus relating to a proposed offer for subscription for...

Dublin, Jan. 12, 2026 (GLOBE NEWSWIRE) -- The "Military Trucks - Market and Technology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. Military trucks are the...

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BYA PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.KEY...

Aclaris Initiates Phase 1b Proof-of-Concept Trial in Atopic Dermatitis (AD) with its Novel Bispecific Antibody ATI-052

YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1.        KEY...